Compare PLRX & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLRX | THFF |
|---|---|---|
| Founded | 2015 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.3M | 686.6M |
| IPO Year | 2020 | N/A |
| Metric | PLRX | THFF |
|---|---|---|
| Price | $1.22 | $62.51 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 3 |
| Target Price | $3.79 | ★ $60.00 |
| AVG Volume (30 Days) | ★ 1.9M | 56.6K |
| Earning Date | 11-06-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 3.58% |
| EPS Growth | N/A | ★ 69.68 |
| EPS | N/A | ★ 6.25 |
| Revenue | N/A | ★ $250,755,000.00 |
| Revenue This Year | N/A | $33.24 |
| Revenue Next Year | N/A | $8.15 |
| P/E Ratio | ★ N/A | $10.01 |
| Revenue Growth | N/A | ★ 31.89 |
| 52 Week Low | $1.10 | $42.05 |
| 52 Week High | $14.26 | $65.79 |
| Indicator | PLRX | THFF |
|---|---|---|
| Relative Strength Index (RSI) | 36.53 | 56.06 |
| Support Level | $1.20 | $62.33 |
| Resistance Level | $1.27 | $65.79 |
| Average True Range (ATR) | 0.07 | 1.26 |
| MACD | 0.00 | -0.35 |
| Stochastic Oscillator | 17.83 | 37.50 |
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.